Dr. S.J.S. Flora, presently Director, National Institute of Pharmaceutical Education and Research, Raebareli, India. Before joining this position he was Associate Director and Head, Division of Pharmacology, Toxicology and Regulatory Toxicology at Defense Research and Development Establishment, Gwalior. He got his Ph.D. in 1985 from Industrial Toxicology Research Center, Lucknow, India and was a postdoctoral research associate at Utah State University, USA. His most highlighted contribution has been the development of a new drug for therapy of chronic arsenic poisoning which has been approved by Drug Controller General of India (DCGI) and is currently undergoing Phase-I clinical trial. He has nearly 285 research papers including more than 80 Review article/chapters in international books, which have been widely cited in the international literature. He is the member, editorial board of 32 international journals like Food & Chemical Toxicology (Elsevier), Journal of Trace Elements in Biology & Medicine (Elsevier), Environmental Research (Elsevier), Ecotoxicology and Environmental Safety (Elsevier), Human & Experimental Toxicology (SAGE UK) and Medicinal Chemistry etc. He is a Fellow of National Academy of Sciences (India) (FNASc) and has number of national and international awards to his credit. He has supervised 25 research students for their Ph.D. degree.
Biography:
Swaran Jeet Singh Flora
National Institute of Pharmaceutical Research
Dr. S.J.S. Flora, presently Director, National Institute of Pharmaceutical Education and Research, Raebareli, India. Before joining this position he was Associate Director and Head, Division of Pharmacology, Toxicology and Regulatory Toxicology at Defense Research and Development Establishment, Gwalior. He got his Ph.D. in 1985 from Industrial Toxicology Research Center, Lucknow, India and was a postdoctoral research associate at Utah State University, USA. His most highlighted contribution has been the development of a new drug for therapy of chronic arsenic poisoning which has been approved by Drug Controller General of India (DCGI) and is currently undergoing Phase-I clinical trial. He has nearly 285 research papers including more than 80 Review article/chapters in international books, which have been widely cited in the international literature. He is the member, editorial board of 32 international journals like Food & Chemical Toxicology (Elsevier), Journal of Trace Elements in Biology & Medicine (Elsevier), Environmental Research (Elsevier), Ecotoxicology and Environmental Safety (Elsevier), Human & Experimental Toxicology (SAGE UK) and Medicinal Chemistry etc. He is a Fellow of National Academy of Sciences (India) (FNASc) and has number of national and international awards to his credit. He has supervised 25 research students for their Ph.D. degree.